SARS-CoV-2 Spike Protein / RBD Human Monoclonal Antibody, IgG1, Clone: [002-S21F2], Unconjugated
Artikelnummer:
BYT-ORB2977660
| Artikelname: |
SARS-CoV-2 Spike Protein / RBD Human Monoclonal Antibody, IgG1, Clone: [002-S21F2], Unconjugated |
| Artikelnummer: |
BYT-ORB2977660 |
| Hersteller Artikelnummer: |
orb2977660 |
| Alternativnummer: |
BYT-ORB2977660-1, BYT-ORB2977660-100 |
| Hersteller: |
Biorbyt |
| Wirt: |
Human |
| Kategorie: |
Antikörper |
| Applikation: |
ELISA, FA, FACS, In vivo |
| Spezies Reaktivität: |
Virus |
| Konjugation: |
Unconjugated |
| Alternative Synonym: |
2, E2, Peplomer protein, S, S glycoprotein, Spike glycoprotein, Spike protein S1, Spike protein S2, Spike protein S2, sars-cov-2 |
| Anti-SARS-CoV-2 Spike Protein/RBD Broad-Neutralizing Antibody (002-S21F2)is a research-grade recombinant antibody targeting Spike glycoprotein . Produced in mammalian cells with native-like glycosylation. Highlights Research Grade - For PK/PD studies, assay development, and ADA research. Native Glycosylation - Mammalian expression ensures native-like patterns. |
| Klonalität: |
Monoclonal |
| Konzentration: |
5.05 mg/ml |
| Klon-Bezeichnung: |
[002-S21F2] |
| Isotyp: |
IgG1 |
| UniProt: |
P0DTC2 |
| Puffer: |
0.01M PBS, pH 7.4. |
| Reinheit: |
>95% purity as determined by SDS-PAGE. |
| Formulierung: |
Liquid |
